Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicorandil Sequential Therapy vs Conventional Use in STEMI
ChiCTR-IPC-16009477Phase 4Not yet recruiting
- Sponsor
- Xijing Hospital
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of nicorandil in myocardial infarction (MI) (2 arms), sponsored by Xijing Hospital. Primary endpoint: infarct size. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
nicorandil
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR-IPC-16009477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPC-16009477.